Bio

He has extensive experience solving the regulatory challenges that arise in the context of cross-border corporate M&A transactions, carve-outs and re-structuring projects, including with respect to permits and licenses, environmental liabilities and product-related registrations. He advises both financial investors and strategic clients regarding a wide range of industry sectors, primarily healthcare, consumer products, chemicals, oil and gas, energy, aviation and general industries. This includes advising clients on the strategic management of regulatory risks and environmental liabilities in large-scale industrial and infrastructure projects such as industrial parks. Michael Ramb also specialises in advising on regulatory product risks and crisis management, primarily in the pharmaceuticals, medical device, food, consumer goods, and chemicals sectors. As well as keeping clients up to speed on the latest regulatory requirements for the production, labelling and distribution of products, he advises on global market access projects, supply-chain compliance, cross-border product recalls, regulatory supervision, product liability and new challenges resulting from the increasing digitalisation of previously unconnected products. He has substantial experience in anti-bribery and corruption compliance, advising companies on cross-border investigations and the implementation of compliance management systems, with a particular focus on the healthcare sector.